Thursday November 14, 2019

Is China trying to revive the Old Silk Route? Find out!

China’s primary focus on culture and history is a sign that this is a way back to a “normal” economy

1
//
Illustrated map depicting the journey of the Venetian merchant Marco Polo (1254 - 1324) along the silk road to China. Image source: MPI/Getty Images
  • The attempt to revive Silk Route is to dig back into its past glories and historical achievements
  • In the oasis city of Dunhuang, the ancient Mogao caves are being restored with special care
  • The first International Expo will take place in the Dunhuang city in September 2016 

The project of developing the Silk Route is neither spontaneous nor coincidental. It is a strategic scheme to keep the accusations that Beijing is enjoying the regional dominance owing to its financial stature, at bay. Analysts opined that it is China’s way of sending a message that the One Belt One Road project is an extension of the peace treaties China had made with Asia and Europe in the ancient times. The new project is to honour that Silk Route which remained the connecting route of theirs for centuries.  The Chinese are aiming at the revival of their agreements with Asia and Europe.

The economically boosted city of Beijing. Image Courtesy : Wikimedia Commons
The economically boosted city of Beijing. Image Courtesy : Wikimedia Commons

“The Silk Road has a shared legacy, for not only did it involve China, but many other countries including India, Russia, and Italy,” said E. Jun, the director of the Gansu Provincial Museum in Lanzhou, the capital of Gansu to The Hindu.

In fact, the museums have antics which remind us of India’s Buddhist connect with China. The museum is under construction but the work is progressing at an extremely triumphant rate. A mega theatre is being built, a few miles away, in the area that falls under the Gobi desert. The scale of cultural infrastructure that is being developed is amazing. China’s primary focus on culture and history is a sign that this is a way back to a “normal” economy. At least, that is what they seem to be aiming at.

The Old Silk Route of Indo-China. Image Courtesy : Wikimedia Commons

Mr Wu pointed told The Hindu that the overall contribution of the “culture industry to the total GDP of the city had already crossed the 55 per cent mark last year, and the figure is expected to rise, as plans to develop infrastructure take root.

The historic Mogao Caves. Image Courtesy : Wikimedia Commons
The historic Mogao Caves. Image Courtesy : Wikimedia Commons

However, the critics perceive the work going on to develop the Silk Route through these plans as “cultural overkill”. They are saying that the attempts made by China to revive their cultural heritage by constructing new cultural sites will result in drawing in a flood of tourists to that particular area and the novelty of the Mogao caves will wear off.

-This article is compiled by a staff-writer at NewsGram.

ALSO READ:

  • Aparna Gupta

    Its really good if they are trying to revive their agreements with Asia and Europe. This will not only help the financial condition of China but also of Asia and Europe.

Next Story

China Okays Sale of First Home-Grown Drug for Treatment of Mild to Moderate Alzheimer’s Disease

A multi-centre global phase 3 clinical trial with sites in the US, Europe and Asia is planned to be initiated in early 2020

0
China, Home, Drug
Oligomannate will provide a new treatment option to fight Alzheimer's disease for patients and is expected to be available in China by the end of 2019, Green Valley Pharmaceutical said on Saturday. Pixabay

China has approved the first home-grown drug for the treatment of “mild to moderate Alzheimer’s disease (AD) and improving cognitive function”, according to its developers.

The new drug, Oligomannate (GV-971), is the first to be approved for Alzheimer’s disease globally since 2003, said Green Valley Pharmaceutical Co., which developed the drug along with Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences.

Oligomannate will provide a new treatment option to fight Alzheimer’s disease for patients and is expected to be available in China by the end of 2019, Green Valley Pharmaceutical said on Saturday.

A multi-centre global phase 3 clinical trial with sites in the US, Europe and Asia is planned to be initiated in early 2020 to support global regulatory filing of Oligomannate.

China, Home, Drug
The new drug, Oligomannate (GV-971), is the first to be approved for Alzheimer’s disease globally since 2003, said Green Valley Pharmaceutical Co., which developed the drug along with Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences. Pixabay

An effective treatment for Alzheimer’s that affects about 48 million people in the world could easily become a big hit globally.

China’s National Medical Products Administration granted Oligomannate fast-track review in November 2018.

Over 800 patients with the diagnosis of mild to moderate Alzhemer’s disease completed the Phase 3 clinical trial conducted in 34 tier-1 hospitals across China.

Results of the 36-week-long study showed that Oligomannate can improve cognitive function in mild-to-moderate Alzheimer’s disease patients as early as week 4 and the benefit was sustained at each follow-up assessment visit.

Also Read- Bengal Focuses on Alternatives after Banning Stubble Burning

Alzheimer’s disease is a progressive brain disorder that impairs memory, affecting the ability of patients to carry out simple tasks. (IANS)